文献速递冠心病血脂与心血管预防

COVID-19疫情期间经皮冠状动脉介入治疗心肌梗死的发生率与结局

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
PubMed 文献 · Heart · 2020-10-06

该研究基于瑞典全国SCAAR注册数据,比较2020年3月1日至5月7日COVID-19疫情期间与2015-2019年同期所有转诊冠状动脉造影的心肌梗死发生率。结果显示疫情期间心肌梗死发生率显著降低(IRR 0.80,95%CI 0.74-0.86,p<0.001),但7天病死率及护理质量指标无显著差异。

要点

  • COVID-19疫情期间瑞典心肌梗死转诊造影发生率较同期下降20%。
  • 各亚组患者类别未见改变,提示求医人群构成稳定。
  • 7天病死率及PCI质量指标无显著差异。

核心结论

  • COVID-19大流行显著降低了接受侵入性治疗策略的心肌梗死发生率。
  • 未观察到短期总病死率或护理质量指标的差异。

研究设计与样本

  • 基于瑞典冠状动脉造影和血管成形术注册登记(SCAAR)的全国性注册研究。
  • 比较2020年3月1日至5月7日与2015-2019年同日期所有转诊冠状动脉造影的心肌梗死患者。

主要发现

  • 疫情期间共2443例心肌梗死转诊造影,发生率为36例/天(204例/10万人年)。
  • 发生率比(IRR)为0.80,95%CI 0.74-0.86,p<0.001。
  • 7天病死率Kaplan-Meier事件率:疫情期间439例(2.3%),参考期37例(2.9%),HR 0.81,95%CI 0.58-1.13,p=0.21。
  • 疫情期间经皮冠状动脉介入治疗(PCI)等待时间更短,PCI执行情况相当。

临床怎么用

  • 疫情期间心肌梗死发生率下降,但患者短期病死率未增加,护理质量指标稳定。
  • 需关注心肌梗死患者求医行为变化,确保及时再灌注治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Most reports on the declining incidence of myocardial infarction (MI) during the COVID-19 have either been anecdotal, survey results or geographically limited to areas with lockdowns. We examined the incidence of MI during the COVID-19 pandemic in Sweden, which has remained an open society with a different public health approach fighting COVID-19. METHODS: We assessed the incidence rate (IR) as well as the incidence rate ratios (IRRs) of all MI referred for coronary angiography in Sweden using the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR), during the COVID-19 pandemic in Sweden (1 March 2020-7 May 2020) in relation to the same days 2015-2019. RESULTS: A total of 2443 MIs were referred for coronary angiography during the COVID-19 pandemic resulting in an IR 36 MIs/day (204 MIs/100 000 per year) compared with 15 213 MIs during the reference period with an IR of 45 MIs/day (254 MIs/100 000 per year) resulting in IRR of 0.80, 95% CI (0.74 to 0.86), p<0.001. Results were consistent in all investigated patient subgroups, indicating no change in patient category seeking cardiac care. Kaplan-Meier event rates for 7-day case fatality were 439 (2.3%) compared with 37 (2.9%) (HR: 0.81, 95% CI (0.58 to 1.13), p=0.21). Time to percutaneous coronary intervention (PCI) was shorter during the pandemic and PCI was equally performed, indicating no change in quality of care during the pandemic. CONCLUSION: The COVID-19 pandemic has significantly reduced the incidence of MI referred for invasive treatment strategy. No differences in overall short-term case fatality or quality of care indicators were observed.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Mohammad MA, Koul S, Olivecrona GK, et al. Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic. Heart. 2020. PMID: 33023905. doi:10.1136/heartjnl-2020-317685

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。